# Ticagrelor and Clopidogrel on Platelet Aggregation in Clopidogrel Resistance's Patients With CHD

> **NCT03614832** · PHASE4 · UNKNOWN · sponsor: **First Affiliated Hospital of Harbin Medical University** · enrollment: 100 (estimated)

## Conditions studied

- Platelet Reactivity

## Interventions

- **DRUG:** Ticagrelor 90 mg
- **DRUG:** Clopidogrel 150 mg

## Key facts

- **NCT ID:** NCT03614832
- **Lead sponsor:** First Affiliated Hospital of Harbin Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-05-01
- **Primary completion:** 2019-05-01
- **Final completion:** 2019-10-01
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2018-08-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03614832

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03614832, "Ticagrelor and Clopidogrel on Platelet Aggregation in Clopidogrel Resistance's Patients With CHD". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03614832. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*